A new drug company to save thousands of lives has taken a step back, citing a shortage of generic versions of Lipitor, the blockbuster anti-obesity drug touted as the best on the market.
Pfizer, a drug giant, announced Monday it would cut its prices on the drug, citing shortages of certain drugs. The company said it will make a profit of $5.4 billion, or roughly half the total sales of the best-selling drug, the biggest in the country, for the third year in a row. The drug's maker, AstraZeneca PLC, said the cut would have a positive impact on the company's bottom line.
"It has been hard for me to work through the uncertainty and uncertainty of the pharmaceutical industry and I believe that the decision to cut prices is not one that would be a positive one," said Scott M. Jones, chief executive officer of Pfizer. "The price of Lipitor is going up a lot."
The company did not immediately comment on whether the company's stock price rose.
The drug's maker, the drug maker, is also facing shortages of generic versions of Lipitor. Pfizer, the nation's largest drug maker, has been forced to cut its prices on several of its drugs, citing a shortage of certain drugs.
The drug maker had a similar shortage of Lipitor, which it said was in effect because it was unable to fill its stockholders' needs.
Pfizer said Monday that it was working with its legal team to make a profit of $5.4 billion, or roughly half of its revenue for the drug's third year. It said it was working with its legal team to make a profit of $6.8 billion, or about half of the total revenue for the drug's second year.
"We are very pleased with the results and are confident that we will continue to work with the legal team and we will make every effort to provide the best possible product to our clients," said Richard B. Johnson, president and chief executive officer of Pfizer, in a statement.
The company said it has a "major share of the revenue" from Lipitor, but did not comment on the amount the company would make.
The company also said it would take steps to reduce its drug costs, by cutting down on the use of other drugs.
The drugmaker said that its patent for Crestor, the generic version of Lipitor, expired in April. That drug, also known as Lipitor, is used to help people with heart disease, cancer, and other ailments.
Crestor, which treats arthritis and muscle-related conditions, is the world's top-selling drug in September. But some doctors say Crestor is too expensive, too expensive, or simply not as good as Lipitor.
Crestor has been a big seller in the drug industry since it was introduced in 1999 as a drug to treat high cholesterol and heart problems.
But it's not the only drug that Pfizer is cutting prices on.
The drugmaker is also looking at a generic version of Lipitor, the little blue pill that has helped people with high cholesterol and arthritis. It will start selling the generic version next month, but the company said that could take time.
The cost of Crestor, the biggest in the country, will come to $1.9 billion in 2013, up from the price of $2.5 billion in 1999.
Pfizer is also raising prices of the brand-name drug Crestor to make it the most popular drug in the United States.
The drugmaker will increase the prices of about 5,000 brands of the drug by 2014, and will make up to $1.8 billion in savings by 2015.
The company's stockholders will get a new incentive program that will allow Pfizer to offer new drugs, including Crestor, with a "promotional" price, if it can be found to be too good to be true.
The announcement comes after the New York company cut prices on two drugs -- cholesterol fighter Lipitor and heart drug Norvasc -- for $1.8 billion. The company said it would not make a profit from the cut.
Pfizer will cut the prices of two other drugs, including Zocor, the company's first-ever generic version of Lipitor, on Wednesday.
Pfizer said Monday that it will offer a new program to help patients and doctors save money on prescriptions.
But drugmakers have long been under pressure to make money, and the industry will likely be under pressure to cut prices in a few years.
Crestor® is a prescription drug that belongs to a class of medications called a corticosteroid. It works by blocking the effects of certain hormones in the body, such as cortisol. This action helps reduce the amount of stress in the body. It is important to take the medicine exactly as prescribed by your healthcare provider, even if you start feeling better. If you do not get any results after taking the medicine, you should consult your doctor to see if there are any other medications you are taking.
Crestor® is also used for the management of certain types of benign prostatic hyperplasia (BPH), an enlarged prostate, and enlarged prostate gland (also known as BPH).
Crestor® is used to treat:
Crestor® may also be used to treat an enlarged prostate.
If you are taking Crestor® and you are experiencing any of the following side effects, contact your healthcare provider:
Crestor® may also be used to treat an enlarged prostate gland.
Salt Composition in both
Salt Composition
Rosuvastatin 20mg(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Rosu Vytorin 20mg Tablet 10s
817+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Submit your medicinePayment MethodsSaving more than namebrand antibiotics
As adidn't sell medicines
CUSTOMER ADMINISTRANT
AstraZeneca Limited (Nasco) is a specialty pharmaceutical company with a rich history. During the 21st century, we specialise in the discovery, development, and commercialisation of a wide range of pharmaceutical products. Our research and development activities are focused on the treatment of a wide range of diseases, including blood clotting disorders, cancer, diabetes, heart failure, inflammation, and pain. Our products are also used in the management of cancer in various countries around the world.
This medicine is independently review supported by the WHO and the European Commission. Please include the latest update as a separate endorsement.ByThe Associated Press
LAS VEGAS (AP) — The United States health department’s drug regulators said Friday that it could sell a generic version of the cholesterol-fighting drug Crestor to treat a rare genetic disorder in the elderly.
“The Food and Drug Administration has identified this issue as a serious medical problem,” said the FDA’s medical director, Dr. Lisa Roach, in a statement.
Crestor, which is used to help high- cholesterol levels, is among the most widely-used statins in the country.
In May, the FDA approved a generic version of the drug, called Crestor, to treat the condition. It is available at pharmacies and online.
Roche’s patent on the drug expired in December, and the drugmaker has agreed to pay the government $1.6 billion for a generic version.
The drugmaker also will pay $2.2 billion to settle lawsuits alleging the drug caused the death of a child in 2002.
The FDA also said that it is taking action against various manufacturers of Crestor for failing to warn consumers about the risk of heart problems. It has said it is “evaluating” the case.
The latest approval comes after a federal appeals court upheld an earlier ruling that the drug maker did not have a demonstrated need for the medication.
The FDA said in a statement that the agency had not made any significant changes to the drug’s labeling or use, but that it is reviewing the matter and plans to take any necessary actions.
The company said the latest warning came after the company conducted additional tests on its own patients and found that patients had been taking the drug for an extended period of time.
Roche, which is based in the Bronx, said in a statement that it was working with its lawyers to file an appeal, and that it was seeking a declaration of a patent infringement.
“This case is about how the FDA and our partners are taking a critical step to assess a medical problem,” said Dr. Steven Nissen, director of the FDA’s Center for Drug Evaluation and Research. “We are committed to making available a generic alternative to Crestor to help patients who may be facing serious health issues.”
Roche is the first major manufacturer of statin drugs to file a patent seeking to market a generic version.
Roche is the first major drugmaker to do so.
The company has a 90-day supply of Crestor at $1.60 per 100 milligram tablet, for $4.10 a dose. It also sells generic versions of cholesterol-fighting drugs, including Lipitor and Zocor.
Roche said it expects Crestor to be available by mid-year, with peak sales expected by mid-July. Sales of the generic version of Crestor reached $3.4 billion last year.
The drugmaker said it will submit its patent application to the Food and Drug Administration before that date.
Roche (NYSE: JAX) and Merck & Co. (MSRP: M& A) (NYSE: MSP) are among the leading U. S. companies in cholesterol-fighting drugs.The U. pharmaceutical company said the company was “complying with FDA’s rigorous review of Crestor’s label and clinical data,” adding that it was taking “committed steps” to address the problem.
Roche also said it would “not delay in production of our new generic version of Crestor until we know the full facts,” but will continue to market the drug. The company did not return a request for comment.
The FDA and its medical regulatory arm, FDA, approved Crestor in May for treating an elderly patient’s “severe form of coronary heart disease,” according to FDA documents and a separate, independent review of the FDA’s review.The drugs work by blocking the effects of a certain enzyme called lipase, which helps block cholesterol from being digested. Lipase is used to make the drug more potent, but is not usually recommended for treating patients with high cholesterol.
The price of crestor is reasonable and it is manufactured by AstraZeneca. Crestor is available in the quantity of one capsule. It has been manufactured by AstraZeneca since 1987.
The dosage of Crestor is 20 mg. In this particular case, the dosage is increased to 40 mg by taking 10 mg once a day. The usual adult dosage is 40 mg once a day, however, in the case of more serious liver or kidney problems, the dosage should be increased to 100 mg once a day, and the dosage may be increased to 120 mg once a day. In case of a severe disease of the nervous system, the dosage is increased to 40 mg once a day, and the dosage may be increased to 120 mg once a day.
As far as rosuvastatin is concerned, Crestor has been shown to be effective in reducing the size of the plaque of the heart valve. In addition to this, the drug has been shown to help to reduce the size of the liver and kidneys.
Crestor is available in the quantity of one tablet. The recommended dosage is 10 mg, and the recommended starting dosage is 20 mg. The dosage of Crestor is 10 mg once a day.
It is not clear how much Crestor is actually used in the body. It has not been shown to be effective in the reduction of the size of the plaque of the heart valve. The recommended starting dosage is 10 mg once a day.
It has been manufactured by AstraZeneca since 1995. Crestor is available as a generic medicine in the quantity of one capsule, and it is available in a different quantity than the one that is marketed.
It is manufactured by AstraZeneca.
Show moreThe price of Crestor is reasonable and it is manufactured by AstraZeneca. It has been shown to be effective in reducing the size of the plaque of the heart valve.
It has been manufactured by AstraZeneca.
Show less
Stade de France Pharmacy